John P. Hamill's Net Worth
$556 Thousand
Who is John P. Hamill?
John P. Hamill does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include WINDTREE THERAPEUTICS INC /DE/, TREVENA INC, Cellectar Biosciences, Inc., and Aprea Therapeutics, Inc..
SEC CIK
John P. Hamill's CIK is 0001716213
Past Insider Trading and Trends
2024 was John P. Hamill's most active year for acquiring shares with 5 total transactions. John P. Hamill's most active month to acquire stocks was the month of February. 2019 was John P. Hamill's most active year for disposing of shares, totalling 1 transactions. John P. Hamill's most active month to dispose stocks was the month of May. 2019 saw John P. Hamill paying a total of $8,700.00 for 7,500 shares, this is the most they've acquired in one year. In 2019 John P. Hamill cashed out on 5,516 shares for a total of $6,453.72, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
WINDTREE THERAPEUTICS INC /DE/ (WINT) Snapshot price: $2.79
SVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.30% | 3K |
$0.37 | $1,099.80 | 72.8K |
Jul 26
| |||
Form 4
| +1,894.29% | 66.3K |
—
|
—
| 69.8K |
Mar 4
| |||
Form 4
| +40.00% | 1K |
$2.07 | $2,066.90 | 3.5K |
Apr 16
| |||
Form 4
| +150.00% | 1.5K |
$3.25 | $4,875.00 | 2.5K |
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
∞
| 1K |
$5.27 | $5,270.00 | 1K |
Oct 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TREVENA INC (TRVN) Snapshot price: $3.83
VP Fin,Princ Fin&Acct Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.47% | 1.98K |
$1.17 | $2,246.28 | 82.23K |
May 31 - Jun 3
| |||
Form 4
| +32,000.00% | 80K |
—
|
—
| 80.25K |
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cellectar Biosciences, Inc. (CLRB) Snapshot price: $2.09
Interim CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aprea Therapeutics, Inc. (APRE) Snapshot price: $3.48
SrVP/CFO/Prin Fin & Acct Ofcr
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.26% | 50 |
$2.46 | $123.19 | 19.37K |
Oct 11
| |||
Form 4
| +2.38% | 450 |
$2.61 | $1,174.50 | 19.32K |
Oct 10
| |||
Form 4
| +21.71% | 3.37K |
—
|
—
| 18.87K |
Mar 28
| |||
Form 4
| +6.97% | 1.01K |
$7.29 | $7,362.90 | 15.5K |
Mar 13
| |||
Form 4
| +7.41% | 1K |
$5.25 | $5,250.00 | 14.49K |
Feb 27
| |||
Form 4
|
∞
| 269.88K |
—
|
—
| 269.88K |
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||